Regulation of adrenocortical cardiotonic steroid production by dopamine and PKA signaling

Frontiers in Bioscience

Volumn 10, Issue SUPPL. 2, 2005, Pages 2489-2495

  Dmitrieva, Renata I ^a   Lalli, Enzo ^b   Doris, Peter A ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

Adrenal Cortex; Dopamine; Marinobufagenin; Protein Kinase A; Receptor

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ALDOSTERONE; CARDIOTONIC AGENT; CYCLIC AMP DEPENDENT PROTEIN KINASE; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR STIMULATING AGENT; DOPAMINE RECEPTOR; FORSKOLIN; HOLOENZYME; PROGESTERONE; RECEPTOR; SODIUM; STEROID;

ADRENAL CORTEX; ADRENAL CORTEX CELL; AGONIST; ALDOSTERONE RELEASE; ANIMAL CELL; ARTICLE; BLOOD VESSEL REACTIVITY; CELL CULTURE; CELL LINE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOPAMINERGIC ACTIVITY; DRUG RECEPTOR BINDING; ENZYME INHIBITION; HYPERTENSION; MOUSE; NERVE CELL CULTURE; NONHUMAN; PHOSPHORYLATION; PROGESTERONE RELEASE; SODIUM URINE LEVEL; STEROIDOGENESIS; VERTEBRATE;

LAKE VICTORIA MARBURGVIRUS; VERTEBRATA;

EID: 21344437080     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/1713     Document Type: Article

References (43)

1. Karet FE and Lifton RP. Mutations contributing to human blood pressure variation. Recent Prog Horm Res 52, 263-276 (1997)
2. Yates NA and McDougall JG. Interaction of exogenous ouabain and chronic mineralocorticoid treatment in the kidney of the conscious sheep. Clin Exp Pharmacol Physiol 24, 57-63 (1997)
3. Yates NA and McDougall JG. Effect of volume expansion on the natriuretic response to ouabain infusion. Ren Physiol Biochem 18, 311-320 (1995)
4. Juhaszova M and Blaustein MP. Na+ pump low and high ouabain affinity alpha subunit isoforms are differently distributed in cells. Proc Natl Acad Sci U S A 94, 1800-1805 (1997)
5. Aperia A. Regulation of sodium/potassium ATPase activity: impact on salt balance and vascular contractility. Curr Hypertens Rep 3, 165-171 (2001)
6. Dmitrieva RI and Doris PA. Ouabain is a potent promoter of growth and activator of ERK1/2 in ouabain-resistant rat renal epithelial cells. J Biol Chem 278, 28160-28166 (2003)
7. Liu J, Tian J, Haas M, Shapiro JI, Askari A, and Xie Z. Ouabain interaction with cardiac Na+/K+-ATPase initiates signal cascades independent of changes in intracellular Na+ and Ca2+ concentrations. J Biol Chem 275, 27838-27844 (2000)
8. Xie Z, Kometiani P, Liu J, Li J, Shapiro JI, and Askari A. Intracellular reactive oxygen species mediate the linkage of Na+/K+-ATPase to hypertrophy and its marker genes in cardiac myocytes. J Biol Chem 274, 19323-19328 (1999)
9. Kometiani P, Li J, Gnudi L, Kahn BB, Askari A, and Xie Z. Multiple signal transduction pathways link Na+/K+-ATPase to growth-related genes in cardiac myocytes. The roles of Ras and mitogen-activated protein kinases. J Biol Chem 273, 15249-15256 (1998)
10. Scheiner-Bobis G and Schoner W. A fresh facet for ouabain action. Nat Med 7, 1288-1289 (2001)
11. Aydemir-Koksoy A, Abramowitz J, and Allen JC. Ouabain-induced signaling and vascular smooth muscle cell proliferation. J Biol Chem 276, 46605-46611 (2001)
12. Haas M, Wang H, Tian J, and Xie Z. Src-mediated inter-receptor cross-talk between the Na+/K+-ATPase and the epidermal growth factor receptor relays the signal from ouabain to mitogen-activated protein kinases. J Biol Chem 277, 18694-18702 (2002)
13. Schoner W. Endogenous cardiotonic steroids. Cell Mol Biol (Noisy-le-grand) 47, 273-280 (2001)
14. Doris PA, Kilgore MW, Durham D, Alberts D, and Stocco DM. An endogenous digitalis-factor derived from the adrenal gland: studies of adrenocortical tumor cells. Endocrinology 125, 2580-2586 (1989)
15. Dmitrieva RI, Bagrov AY, Lalli E, Sassone-Corsi P, Stocco DM, and Doris PA. Mammalian bufadienolide is synthesized from cholesterol in the adrenal cortex by a pathway that Is independent of cholesterol side-chain cleavage. Hypertension 36, 442-448 (2000)
16. Bagrov AY, Fedorova OV, Dmitrieva RJ, Howald WN, Hunter AP, Kuznetsova EA, and Shpen VM. Characterization of a urinary bufodienolide Na+,K+-ATPase inhibitor in patients after acute myocardial infarction. Hypertension 31, 1097-1103 (1998)
17. Bagrov AY, Fedorova OV, Dmitrieva RI, French AW, and Anderson DE. Plasma marinobufagenin-like and ouabain-like immunoreactivity during saline volume expansion in anesthetized dogs. Cardiovasc Res 31, 296-305 (1996)
18. Fedorova OV, Doris PA, and Bagrov AY. Endogenous marinobufagenin-like factor in acute plasma volume expansion. Clin Exp Hypertens 20, 581-591 (1998)
19. Buu NT and Lussier C. Origin of dopamine in the rat adrenal cortex. Am J Physiol 258, F287-291 (1990)
20. Aherne AM, Vaughan CJ, Carey RM, and O'Connell DP. Localization of dopamine D1A receptor protein and messenger ribonucleic acid in rat adrenal cortex. Endocrinology 138, 1282-1288 (1997)
21. Missale C, Liberini P, Memo M, Carruba MO, and Spano P. Characterization of dopamine receptors associated with aldosterone secretion in rat adrenal glomerulosa. Endocrinology 119, 2227-2232 (1986)
22. Missale C, Memo M, Liberini P, and Spano P. Dopamine selectively inhibits angiotensin II-induced aldosterone secretion by interacting with D-2 receptors. J Pharmacol Exp Ther 246, 1137-1143 (1988)
23. Stern N, Tuck M, Ozaki L, and Krall JF. Dopaminergic binding and inhibitory effect in the bovine adrenal zona glomerulosa. Hypertension 8, 203-210 (1986)
24. Meister B, Schultzberg M, Hemmings HC, Jr., Greengard P, Goldstein M, and Hokfelt T. Dopamine- and adenosine-3′,5′-monophosphate (cAMP)-regulated phosphoprotein of 32 kDa (DARPP-32) in the adrenal gland: immunohistochemical localization. J Auton Nerv Syst 36, 75-84 (1991)
25. Aguilera G and Catt KJ. Dopaminergic modulation of aldosterone secretion in the rat. Endocrinology 114, 176-181 (1984)
26. Aperia A, Bertorello A, and Seri I. Dopamine causes inhibition of Na+-K+-ATPase activity in rat proximal convoluted tubule segments. Am J Physiol 252, F39-45 (1987)
27. Chen CJ, Apparsundaram S, and Lokhandwala MF. Intrarenally produced angiotensin II opposes the natriuretic action of the dopamine-1 receptor agonist fenoldopam in rats. J Pharmacol Exp Ther 256, 486-491 (1991)
28. Cheng HF, Becker BN, and Harris RC. Dopamine decreases expression of type-1 angiotensin II receptors in renal proximal tubule. J Clin Invest 97, 2745-2752 (1996)
29. Aperia A, Holtback U, Syren ML, Svensson LB, Fryckstedt J, and Greengard P. Activation/deactivation of renal Na+,K(+)-ATPase: a final common pathway for regulation of natriuresis. Faseb J 8, 436-439 (1994)
30. Lalli E, Melner MH, Stocco DM, and Sassone-Corsi P. DAX-1 blocks steroid production at multiple levels. Endocrinology 139, 4237-4243 (1998)
31. Aperia A, Eklof AC, Holtback U, Nowicki S, Sundelof M, and Greengard P. The renal dopamine system. Adv Pharmacol 42, 870-873, (1998)
32. Fryckstedt J, Meister B, and Aperia A. Control of electrolyte transport in the kidney through a dopamine- and cAMP-regulated phosphoprotein, DARPP-32. J Auton Pharmacol 12, 183-189 (1992)
33. Parker KL and Schimmer BP. Genetics of the development and function of the adrenal cortex. Rev Endocr Metab Disord 2, 245-252 (2001)
34. Jose PA, Eisner GM, and Felder RA. Renal dopamine and sodium homeostasis. Curr Hypertens Rep 2, 174-183 (2000)
35. Carey RM, Thorner MO, and Ortt EM. Effects of metoclopramide and bromocriptine on the renin-angiotensin-aldosterone system in man. Dopaminergic control of aldosterone. J Clin Invest 63, 727-735 (1979)
36. Noth RH, McCallum RW, Contino C, and Havelick J. Tonic dopaminergic suppression of plasma aldosterone. J Clin Endocrinol Metab 51, 64-69 (1980)
37. Sowers JR, Brickman AS, Sowers DK, and Berg G. Dopaminergic modulation of aldosterone secretion in man is unaffected by glucocorticoids and angiotensin blockade. J Clin Endocrinol Metab 52, 1078-1084 (1981)
38. Missale C, Nash SR, Robinson SW, Jaber M, and Caron MG. Dopamine receptors: from structure to function. Physiol Rev 78, 189-225 (1998)
39. Gallo-Payet N, Chouinard L, Balestre MN, and Guillon G. Mechanisms involved in the interaction of dopamine with angiotensin II on aldosterone secretion in isolated and cultured rat adrenal glomerulosa cells. Mol Cell Endocrinol 81, 11-23, (1991)
40. Doris PA, Hayward-Lester A, Bourne D, and Stocco DM. Ouabain production by cultured adrenal cells. Endocrinology 137, 533-539 (1996)
41. Schimmer BP. The 1994 Upjohn Award Lecture. Molecular and genetic approaches to the study of signal transduction in the adrenal cortex. Can J Physiol Pharmacol 73, 1097-1107 (1995)
42. Michel JJ and Scott JD. Akap mediated signal transduction. Annu Rev Pharmacol Toxicol 42, 235-257 (2002)
43. Colledge M and Scott JD. AKAPs: from structure to function. Trends Cell Biol 9, 216-221 (1999)